RXL News Alert Ultra Health Care Proshares (RXL) 131.80 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ultra Health Care Proshares (RXL) 131.80 $RXL

Where Do Cures Reside? The Answer Is In Regenerative Medicine
Life Sciences Report - Seeking Alpha - Fri Jan 09, 7:37AM CST
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones-and investors in the space should strap in for a rewarding joy...
BBP: 28.36 (+0.12), RXL: 131.80 (+1.10), XBI: 203.40 (+1.36), IHE: 163.48 (+1.38), IHF: 123.33 (-0.30), PPH: 67.69 (+0.60), XHE: 91.74 (+0.76), BBC: 28.98 (+0.18), PTH: 56.26 (+0.35), BBH: 122.45 (+0.86), FHLC: 34.19 (+0.16), IHI: 117.25 (+0.94), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), RYH: 148.64 (+0.75), PBE: 52.78 (+0.30), IYH: 149.63 (+0.84), FBT: 110.21 (+1.02), XHS: 116.43 (-0.07), XPH: 118.58 (+0.98), XLV: 70.72 (+0.28), SBIO: 27.28 (+0.14), PSCH: 63.77 (+0.26), PJP: 73.81 (+0.69), RXD: 13.98 (-0.26)

Kyle Bass's Assault On Pharma Patents
IP Hawk - at Seeking Alpha - Thu Jan 08, 12:25PM CST

BBP: 28.36 (+0.12), RXL: 131.80 (+1.10), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04), IHE: 163.48 (+1.38), IHF: 123.33 (-0.30), BBC: 28.98 (+0.18), PPH: 67.69 (+0.60), XHE: 91.74 (+0.76), PTH: 56.26 (+0.35), BBH: 122.45 (+0.86), FHLC: 34.19 (+0.16), IHI: 117.25 (+0.94), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), RYH: 148.64 (+0.75), PBE: 52.78 (+0.30), IYH: 149.63 (+0.84), FBT: 110.21 (+1.02), XHS: 116.43 (-0.07), XPH: 118.58 (+0.98), XLV: 70.72 (+0.28), SBIO: 27.28 (+0.14), PSCH: 63.77 (+0.26), PJP: 73.81 (+0.69), RXD: 13.98 (-0.26)

Anixter International: No Suitor Could Be Found
Alpha Gen Capital - at Seeking Alpha - Sat Dec 27, 9:55AM CST

AXE: 76.07 (+0.44), RXL: 131.80 (+1.10)

20.2% Return Seen to Date on SmarTrend ProShares Ultra Health Care Call (RXL)
Comtex SmarTrend(R) - Mon Dec 15, 9:27AM CST
SmarTrend identified an Uptrend for ProShares Ultra Health Care (NYSE:RXL) on October 21st, 2014 at $104.61. In approximately 2 months, ProShares Ultra Health Care has returned 20.21% as of today's recent price of $125.75.
RXL: 131.80 (+1.10)

ProShares Ultra Health Care Up 25.1% Since SmarTrend Uptrend Call (RXL)
Comtex SmarTrend(R) - Fri Dec 05, 4:54PM CST
SmarTrend identified an Uptrend for ProShares Ultra Health Care (NYSE:RXL) on October 21st, 2014 at $104.61. In approximately 2 month, ProShares Ultra Health Care has returned 25.05% as of today's recent price of $130.82.
RXL: 131.80 (+1.10)

Shares of RXL Up 22.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 28, 11:11AM CST
SmarTrend identified an Uptrend for ProShares Ultra Health Care (NYSE:RXL) on October 21st, 2014 at $104.61. In approximately 1 month, ProShares Ultra Health Care has returned 22.27% as of today's recent price of $127.91.
RXL: 131.80 (+1.10)

Shares of RXL Up 16.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Nov 19, 5:02PM CST
SmarTrend identified an Uptrend for ProShares Ultra Health Care (NYSE:RXL) on October 21st, 2014 at $104.61. In approximately 4 weeks, ProShares Ultra Health Care has returned 16.81% as of today's recent price of $122.20.
RXL: 131.80 (+1.10)

ProShares Ultra Health Care Has Returned 14.4% Since SmarTrend Recommendation (RXL)
Comtex SmarTrend(R) - Wed Nov 12, 11:14AM CST
SmarTrend identified an Uptrend for ProShares Ultra Health Care (NYSE:RXL) on October 21st, 2014 at $104.61. In approximately 3 weeks, ProShares Ultra Health Care has returned 14.37% as of today's recent price of $119.64.
RXL: 131.80 (+1.10)

Healthy Returns From The Healthcare Sector
Sy Harding - at Seeking Alpha - Mon Nov 10, 8:09AM CST
Healthcare stocks, along with the stocks of food and drink companies are often recommended as defensive holdings for bear markets, on the premise that no matter what happens people will always have to eat, drink, and take their medicine. The other...
RYH: 148.64 (+0.75), IYH: 149.63 (+0.84), RXL: 131.80 (+1.10), FHLC: 34.19 (+0.16), RXD: 13.98 (-0.26), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), XLV: 70.72 (+0.28)

15.8% Return Seen to Date on SmarTrend ProShares Ultra Health Care Call (RXL)
Comtex SmarTrend(R) - Wed Nov 05, 9:57AM CST
SmarTrend identified an Uptrend for ProShares Ultra Health Care (NYSE:RXL) on October 21st, 2014 at $104.61. In approximately 2 weeks, ProShares Ultra Health Care has returned 15.78% as of today's recent price of $121.12.
RXL: 131.80 (+1.10)

Top 10 Momentum ETFs For October 27, 2014
CapitalCube - Seeking Alpha - Tue Oct 28, 12:11PM CDT
By Veibha Subramaniam The data was compiled using CapitalCube's ETF Screener Utilities and Health care were the biggest gainers Momentum ETFs have been identified as those ETFs that are trading at a price discount to their 52 week high...
IYH: 149.63 (+0.84), VDC: 127.48 (-0.41), RXL: 131.80 (+1.10), DTO: 81.31 (-5.12), UXI: 120.00 (+1.61), UPW: 97.56 (-2.59), XLU: 45.17 (-0.70), TQQQ: 106.86 (+2.63), SCO: 70.05 (-3.45), QLD: 145.98 (+2.45), IHE: 163.48 (+1.38), XLP: 49.50 (-0.23), FBG: 57.90 (+0.50), UGE: 100.04 (+0.53), IDU: 113.30 (-1.71), SPHD: 33.19 (-0.15), FHLC: 34.19 (+0.16), VPU: 98.07 (-1.43), RHS: 107.77 (-0.29), CURE: 135.77 (+1.84)

True Fund Costs: Health Care Sector
David Trainer - Seeking Alpha - Tue Oct 21, 8:30AM CDT
This report focuses on providing investors the true costs incurred when investing in Health Care ETFs and mutual funds. A key component of our fund ratings, Total Annual Cost (TAC) accounts for all the costs borne by investors, including...
RXL: 131.80 (+1.10), PJP: 73.81 (+0.69), BIB: 141.30 (+2.39), PTH: 56.26 (+0.35), FXH: 62.97 (+0.34)

ProShares Ultra Health Care Up 11.3% Since SmarTrend Uptrend Call (RXL)
Comtex SmarTrend(R) - Fri Sep 19, 11:20AM CDT
SmarTrend identified an Uptrend for ProShares Ultra Health Care (NYSE:RXL) on August 15th, 2014 at $100.99. In approximately 1 month, ProShares Ultra Health Care has returned 11.33% as of today's recent price of $112.43.
RXL: 131.80 (+1.10)

ProShares Ultra Health Care Shares Up 14.3% Since SmarTrend's Buy Recommendation (RXL)
Comtex SmarTrend(R) - Wed Jul 23, 9:58AM CDT
SmarTrend identified an Uptrend for ProShares Ultra Health Care (NYSE:RXL) on April 22nd, 2014 at $88.79. In approximately 3 months, ProShares Ultra Health Care has returned 14.32% as of today's recent price of $101.50.
RXL: 131.80 (+1.10)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

ITRI Awarded for Innovations in Medicine and Sustainability

Updated Category News Views 225

ITRI Celebrates R&D 100 Awards for Innovation The Industrial Technology Research Institute (ITRI) has received widespread recognition for its pioneering technologies. This year, ITRI was honored with three prestigious R&D 100 Awards for 2025, celebrating its innovations in regenerative medicine and sustainable technologies. These awards highlight the Institute's...

Continue Reading
Soaring Wealth Gap in America: Billionaires Gain $698 Billion

Updated Category News Views 336

The Growing Wealth Divide in America The wealth gap in America has reached alarming proportions, with the wealthiest billionaires significantly increasing their fortunes. Reports indicate that the 10 richest billionaires in the U.S. collectively added an astonishing $698 billion to their wealth over the past year. This impressive increase raises critical questions about...

Continue Reading
Laparoscopic Appendectomy Market Growth Forecast for 2032

Updated Category News Views 118

Laparoscopic Appendectomy Market Growth Overview As minimally invasive surgical techniques evolve, the laparoscopic appendectomy market is becoming a key focus within the healthcare sector. It is expected to reach USD 3.83 billion by 2032, marking a substantial growth from USD 2.46 billion in 2023, driven primarily by an increasing incidence of appendicitis and a...

Continue Reading
Replay Sports Cards Launches First Franchise Partnership

Updated Category News Views 141

Replay Sports Cards Launches First Franchise Partnership Replay Sports Cards, a pioneer in the national sports card industry, has reached an exciting milestone by awarding its very first franchise to business partners Josh Stigdon and Jason Buckel. This new partnership represents a significant step in the company's journey to expand its unique card shop model across the...

Continue Reading
S3 Connected Health Honored with Global Company of the Year Award

Updated Category News Views 169

S3 Connected Health Achieves Global Recognition S3 Connected Health has made significant strides in redefining medical device connectivity, enhancing home-based care, and delivering exceptional value within global healthcare frameworks. This innovation is critical as the healthcare sector continues to evolve to meet the needs of patients and providers alike....

Continue Reading